Boston Scientific Operating Income decreased by 21.3% to $825.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 22.2%, from $675.00M to $825.00M. Over 4 years (FY 2021 to FY 2025), Operating Income shows an upward trend with a 31.8% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Growth in operating income suggests that the core business is becoming more profitable and efficient.
The profit realized from a business's own operations after deducting operating expenses like wages, depreciation, and co...
This is a key metric for comparing the fundamental business performance of companies with different tax or debt structures.
is_operating_income| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $262.00M | $387.00M | $180.00M | $466.00M | $423.00M | $358.00M | $402.00M | $552.00M | $514.00M | $693.00M | $584.00M | $675.00M | $520.00M | $733.00M | $675.00M | $921.00M | $819.00M | $1.05B | $825.00M |
| QoQ Change | — | +47.7% | -53.5% | +158.9% | -9.2% | -15.4% | +12.3% | +37.3% | -6.9% | +34.8% | -15.7% | +15.6% | -23.0% | +41.0% | -7.9% | +36.4% | -11.1% | +28.0% | -21.3% |
| YoY Change | — | — | — | — | +61.5% | -7.5% | +123.3% | +18.5% | +21.5% | +93.6% | +45.3% | +22.3% | +1.2% | +5.8% | +15.6% | +36.4% | +57.5% | +43.0% | +22.2% |